Point Mutations in the HIV-1 Matrix Protein Turn Off the Myristyl Switch

Journal of Molecular Biology

Volumn 366, Issue 2, 2007, Pages 574-585

  Saad, Jamil S ^a   Loeliger, Erin ^a   Luncsford, Paz ^a   Liriano, Mellisa ^a   Tai, Janet ^a   Kim, Andrew ^a   Miller, Jaime ^a   Joshi, Anjali ^b   Freed, Eric O ^b   Summers, Michael F ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gag; human immunodeficiency virus type 1; matrix; myristyl; phosphatidylinositol 4,5 bisphosphate

Indexed keywords

MATRIX PROTEIN; MUTANT PROTEIN; MYRISTIC ACID; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL MEMBRANE; CONCENTRATION RESPONSE; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE BINDING; MYRISTYLATION; NUCLEAR MAGNETIC RESONANCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33846400368     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.11.068     Document Type: Article

References (48)

1. Coffin J.M., Hughes S.H., and Varmus H.E. Retroviruses (1997), Cold Spring Harbor Laboratory Press, Plainview, NY
2. Morita E., and Sundquist W.I. Retrovirus budding. Annu. Rev. Cell Devel. Biol. 20 (2004) 395-425
3. von Schwedler U.K., Stuchell M., Muller B., Ward D.M., Chung H.Y., Morita E., et al. The protein network of HIV budding. Cell 114 (2003) 701-713
4. Dong X., Li H., Derdowski A., Ding L., Burnett A., Chen X., et al. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell 120 (2005) 663-674
5. Hermida-Matsumoto L., and Resh M.D. Localization of human immunodeficiency virus type 1 Gag and env at the plasma membrane by confocal imagine. J. Virol. 74 (2000) 8670-8679
6. Nguyen D.G., Booth A., Gould S.J., and Hildreth J.E. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 278 (2003) 52347-52354
7. Ono A., and Freed E.O. Cell-Type-Dependent tageting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J. Virol. 78 (2004) 1552-1563
8. Raposo G., Moore M., Innes D., Leijendekker R., Leigh-Brown A., Benaroch P., and Geuze H. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3 (2002) 718-729
9. Jouvenet N., Neil S.J.D., Bess C., Johnson M.C., Virgen C.A., Simon S.M., and Bieniasz P.D. Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 4 (2006) 2296-2310
10. Ono A., and Freed E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl Acad. Sci. USA 98 (2001) 13925-13930
11. Ono A., and Freed E.O. Role of lipid rafts in virus replication. Adv. Virus Res. 64 (2005) 311-358
12. Yuan X., Yu X., Lee T.-H., and Essex M. Mutations in the N-terminal region of uman immunodeficiency virus type I matrix protein block intracellular transport of the Gag precursor. J. Virol. 67 (1993) 6387-6394
13. Zhou W., Parent L.J., Wills J.W., and Resh M.D. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68 (1994) 2556-2569
14. Bryant M., and Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl Acad. Sci. USA 87 (1990) 523-527
15. Copeland N.G., Jenkins N.A., Nexo B., Schultz A.M., Rein A., Mikkelsen T., and Jorgensen P. Poorly expressed endogenous ecotropic provirus of DBA/2 mice encodes a mutant Pr65gag protein that is not myristylated. J. Virol. 62 (1988) 479-487
16. Göttlinger H.G., Sodroski J.G., and Haseltine W.A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 86 (1989) 5781-5785
17. Spearman P., Horton R., Ratner L., and Kuli-Zade I. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J. Virol. 71 (1997) 6582-6592
18. Spearman P., Wang J.-J., Vander Heyden N., and Ratner L. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68 (1994) 3232-3242
19. Freed E.O., Orenstein J.M., Buckler-White A.J., and Martin M.A. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68 (1994) 5311-5320
20. Ono A., Orenstein J.M., and Freed E.O. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. J. Virol. 74 (2000) 2855-2866
21. Bouamr F., Scarlata S., and Carter C.A. Role of myristylation in HIV-1 Gag assembly. Biochemistry 42 (2003) 6408-6417
22. Zhou W., and Resh M.D. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70 (1996) 8540-8548
23. Lindwasser O.W., and Resh M.D. Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding. Proc. Natl Acad. Sci. USA 99 (2002) 13037-13042
24. Ono A., and Freed E.O. Binding of Human Immunodeficiency Virus Type 1 gag to membrane: role of the matrix amino terminus. J. Virol. 73 (1999) 4136-4144
25. Ono A., Huang M., and Freed E.O. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions. J. Virol. 71 (1997) 4409-4418
26. Paillart J.-C., and Gottlinger H.G. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of Gag membrane targeting. J. Virol. 73 (1999) 2604-2612
27. Tang C., Loeliger E., Luncsford P., Kinde I., Beckett D., and Summers M.F. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl Acad. Sci. USA 101 (2004) 517-522
28. Martin T.F.J. PI(4,5)P2 regulation of surface membrane traffic. Curr. Opin. Cell Biol. 13 (2001) 493-499
29. Behnia R., and Munro S. Organelle identity and the signposts for membrane traffic. Nature 438 (2005) 597-604
30. McLaughlin S., and Murray D. Plasma membrane phosphoinositide organization by protein electrostatics. Nature 438 (2005) 605-611
31. Saad J.S., Miller J., Tai J., Kim A., Ghanam R.H., and Summers M.F. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl Acad. Sci. USA 103 (2006) 11364-11369
32. Ono A., Ablan S.D., Lockett S.J., Nagashima K., and Freed E.O. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl Acad. Sci. USA 101 (2004) 14889-14894
33. Joshi A., Nagashima K., and Freed E.O. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation. J. Virol. 80 (2006) 7939-7951
34. Ono A., Demirov D., and Freed E.O. Relationship between human immunodeficiency virus Type-1 Gag multimerization and membrane binding. J. Virol. 74 (2000) 5142-5150
35. Freed E.O., Englund G., and Martin A.M. Role of the basic domain of human immondeficiency virus type 1 matrix in macrophage infection. J. Virol. 69 (1995) 3949-3954
36. Hill C.P., Worthylake D., Bancroft D.P., Christensen A.M., and Sundquist W.I. Crystal structures of the trimeric HIV-1 Matrix Protein: implications for membrane association. Proc. Natl Acad. Sci. USA 93 (1996) 3099-3104
37. Gonzalez S.A., and Affranchino J.L. Substitution of Leucine 8 in simian immunodeficiency virus matrix protein impairs particle formation without affecting N-Myristylation of the gag precursor. Virology 240 (1998) 27-35
38. Massiah M.A., Starich M.R., Paschall C., Summers M.F., Christensen A.M., and Sundquist W.I. Three dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol. Biol. 244 (1994) 198-223
39. Rao Z., Belyaev A.S., Fry E., Roy P., Jones I.M., and Stuart D.I. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 378 (1995) 743-747
40. Marley J., Lu M., and Bracken C. A method for efficient isotopic labeling of recombinant proteins. J. Biomol. NMR 20 (2001) 71-75
41. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
42. Johnson B.A., and Blevins R.A. NMRview: a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4 (1994) 603-614
43. Wüthrich K. NMR of Proteins and Nucleic Acids (1986), John Wiley & Sons, New York
44. Kay L.E., Clore G.M., Bax A., and Gronenborn A.M. Four-dimensional heteronuclear triple-resonance NMR spectroscopy of interleukin-1β in solution. Science 249 (1990) 411-414
45. Folkers P.J.M., Folmer R.H.A., Konings R.N.H., and Hilbers C.W. Overcoming the ambiguity problem encountered in the analysis of nuclear Overhauser magnetic resonance spectra of symmetric dimer proteins. J. Am. Chem. Soc. 115 (1993) 3798-3799
46. Ishii Y., Markus M.A., and Tycko R. Controlling residual dipolar couplings in high-resolution NMR of proteins by strain induced alignment in a gel. J. Biomol. NMR 21 (2001) 141-151
47. Chou J.J., Gaemers S., Howder B., Louis J.M., and Bax A. A simple apparatus for generating streched polyacrylamide gels, yeilding uniform alignment of proteins and detergent micelles. J. Biomol. NMR 21 (2001) 377-382
48. Johnson M.L., and Faunt L.M. Parameter estimation by least-squares methods. Methods Enzymol. 210 (1992) 1-37